MIRA INFORM REPORT

 

 

Report No. :

336525

Report Date :

13.08.2015

 

IDENTIFICATION DETAILS

 

Name :

BAL PHARMA LIMITED

 

 

Registered Office :

21 and 22, Bommasandra, Industrial Area, Bangalore-562158, Karnataka

Tel. No.:

91-80-22354057

 

 

Country :

India

 

 

Financials (as on) :

31.03.2015

 

 

Date of Incorporation :

19.05.1987

 

 

Com. Reg. No.:

08-008368

 

 

Capital Investment / Paid-up Capital :

Rs. 128.724 Million

 

 

CIN No.:

[Company Identification No.]

L85110KA1987PLC008368

 

 

IEC No.:

0791011739

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BLRB00607F

 

 

PAN No.:

[Permanent Account No.]

AABCB0512E

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Manufacturing and Marketing of Pharmaceutical Formulations and Active Pharmaceutical Ingredients.

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (50)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 1588000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Exist

 

 

Comments :

Subject is an established company having satisfactory track record.

 

General financial position of the company seems to be sound and healthy. Profitability of the company is fair.

 

Trade relations are fair. Business is active. Payment terms are reported to be usually correct.

 

The company can be considered for business dealings at usual trade terms and condition.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 


 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

ICRA

Rating

Long Term Loans = BBB-

Rating Explanation

Moderate degree of safety and moderate credit risk

Date

April 2014

 

 

Rating Agency Name

ICRA

Rating

Non fund based facilities = A3

Rating Explanation

Moderate degree of safety and high credit risk

Date

April 2014

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2013.

 


 

INFORMATION DECLINED

 

MANAGEMENT NON-COOPERATIVE

 

(Contact No: 91-80-41379500)

 

 

LOCATIONS

 

Registered Office/ Factory 1 (Formulations) :

21 and 22, Bommasandra, Industrial Area, Bangalore-562158, Karnataka, India

Tel. No.:

91-80-22354057/ 22354058

Fax No.:

91-80-22354057/ 22354058

E-Mail :

secretarial@balpharma.com

Website :

http://www.balpharma.com

http://www.kdpma.in/bal-pharma

 

 

Corporate Office :

5th Floor, Lakshmi Narayan Complex, 10/1, Palace Road, Bangalore – 560052, Karnataka, India

Tel. No.:

91-80-41379500

Fax No.:

91-80-22354057

 

 

Factory 2 (R AND D Centre and Bulk Drugs) :

No. 61/B, Bommasandra Industrial Area, Hosur Road, Bangalore – 560099, Karnataka, India

 

 

Factory 3 (Parenterals) :

No. 732/735, Off. National Highway, No.4, Village Kenjal, District Bhor – 412217, Maharashtra, India

 

 

Factory 4 (Formulations plant at Uttarakhand) :

Plot No. 1, 2, 3 and 69, Sector 4, IIE-Pantnagar, Rudrapur – 263153, Udham Singh Nagar, Uttarakhand, India

 

 

Factory 5 (Intermediaries) :

Alp-Thabdewadi, Taluka - Kavathe Mahankal, Sangli – 416405, Maharashtra, India

 

 

DIRECTORS

 

AS ON 31.03.2014

 

Name :

Mr. Shailesh D. Siroya

Designation :

Managing Director

Date of Birth/Age :

48 Years

Qualification :

MBA (Finance)

Experience :

22 Years

Date of Appointment :

01.08.1994

 

 

Name :

Dr. S. Prasanna

Designation :

Whole Time Director

 

 

Name :

Mr. Shrenik Siroya

Designation :

Non-Executive Director

Date of Birth/Age :

10.09.1964

Qualification :

B.E

Experience/ Expertise :

Mr. Shernik Siroya is having vast experience in managing various business including Pharma and Construction.

Date of Appointment :

30.09.1997

Other Directorship :

 

·         Siroya Exports (Private) Limited-Director

·         Siroya Developers (Private) Limited-Director

·         Mokalsor Stone Private Limited -Director

·         Siroya FM Constructions Private Limited-Director.

·         Siroya Nabar Hosing Private Limited -Director

·         Mannath Developers (Private) Limited-Director

·         Mannath Properties (Private) Limited -Director.

 

 

Name :

Dr. G.S.R. Subba Rao

Designation :

Independent Director

Date of Birth/Age :

2I.08.I937

Qualification :

Phd, FA. Sc

Experience/ Expertise :

Formerly professor and Dean in Indian Institute of Science (IISC), Bangalore. He is also a consultant to many Indian and Foreign Pharmaceutical Companies on   synthesis   of   drugs,   intermediates, natural products and Steroid hormones.

Date of Appointment :

09.12.1999

 

 

Name :

Mr. Pramod Kumar S.

Designation :

Independent Director

Date of Birth/Age :

15.07.1968

Qualification :

B. Com

Experience/ Expertise :

Mr.Pramod Kumar. S have over 15 years of experience in managing Agro and Pharma industries.

Date of Appointment :

10.05.2012

Other Directorship :

 

·         Sunil Agro Foods Limited-Director.

·         Brindavan Soft land Private Limited -Director

 

 

Name :

Mr. Ajit Kumar

Designation :

Nominee Director

 

 

KEY EXECUTIVES

 

Name :

Mr. V. Murali

Designation :

AVP Finance and Accounts and Company Secretary

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.06.2015

 

Category of Shareholders

No. of Shares

 

Percentage of Holding

(A) Shareholding of Promoter and Promoter Group

 

 

http://www.bseindia.com/include/images/clear.gif(1) Indian

 

 

http://www.bseindia.com/include/images/clear.gifIndividuals / Hindu Undivided Family

4319779

33.56

http://www.bseindia.com/include/images/clear.gifBodies Corporate

1310836

10.18

http://www.bseindia.com/include/images/clear.gifSub Total

5630615

43.74

http://www.bseindia.com/include/images/clear.gif(2) Foreign

 

 

http://www.bseindia.com/include/images/clear.gifIndividuals (Non-Residents Individuals / Foreign Individuals)

655187

5.09

http://www.bseindia.com/include/images/clear.gifSub Total

655187

5.09

Total shareholding of Promoter and Promoter Group (A)

6285802

48.83

(B) Public Shareholding

 

 

http://www.bseindia.com/include/images/clear.gif(1) Institutions

 

 

http://www.bseindia.com/include/images/clear.gifMutual Funds / UTI

200

0.00

http://www.bseindia.com/include/images/clear.gifFinancial Institutions / Banks

1800

0.01

http://www.bseindia.com/include/images/clear.gifSub Total

2000

0.02

http://www.bseindia.com/include/images/clear.gif(2) Non-Institutions

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

560893

4.36

http://www.bseindia.com/include/images/clear.gifIndividuals

 

 

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital up to Rs. 0.100 Million

3033019

23.56

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital in excess of Rs. 0.100 Million

2990658

23.23

http://www.bseindia.com/include/images/clear.gifSub Total

6584570

51.15

Total Public shareholding (B)

6586570

51.17

Total (A)+(B)

12872372

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

 

 

http://www.bseindia.com/include/images/clear.gif(1) Promoter and Promoter Group

0

0.00

http://www.bseindia.com/include/images/clear.gif(2) Public

0

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

0

0.00

Total (A)+(B)+(C)

12872372

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing and Marketing of Pharmaceutical Formulations and Active Pharmaceutical Ingredients.

 

 

Brand Names :

--

 

 

Agencies Held :

--

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

PRODUCTION STATUS: NOT AVAILABLE

 


 

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Divulged

Name of the Person (Designation):

Not Divulged

Contact Number:

Not Divulged

Since how long known:

Not Divulged

Maximum limit dealt:

Not Divulged

Experience:

Not Divulged

Remark

Not Divulged

 

 

Customers :

Reference:

Not Divulged

Name of the Person (Designation):

Not Divulged

Contact Number:

Not Divulged

Since how long known:

Not Divulged

Maximum limit dealt:

Not Divulged

Experience:

Not Divulged

Remark

Not Divulged

 

 

No. of Employees :

Not Divulged

 

 

Bankers :

Bank Name:

Not Divulged

Branch:

Not Divulged

Person Name (with Designation):

Not Divulged

Contact Number:

Not Divulged

Name of Account Holder:

Not Divulged

Account Number:

Not Divulged

Account Since (Date/ Year of A/c Opening):

Not Divulged

Average Balance Maintained (Optional):

Not Divulged

Credit Facilities Enjoyed (CC/OD/Term Loan):

Not Divulged

Account Operation:

Not Divulged

Remarks:

Not Divulged

 

·         Canara Bank

·         EXIM Bank

·         Punjab National Bank Limited

 

 

Facilities :

SECURED LOANS

31.03.2014

(Rs. In Million)

31.03.2013

(Rs. In Million)

LONG-TERM BORROWINGS

 

 

Term Loans

 

 

From Banks

 

 

Exim Bank

60.000

0.000

From Financial Institution

 

 

Kotak Mahindra Prime Limited

0.000

3.217

Other Loans and Advances

 

 

- Vehicle loan

5.796

6.745

 

 

 

SHORT TERM BORROWINGS

 

 

From Banks

 

 

- Cash credit

210.506

233.231

- Packing credit

48.485

54.805

- Bills Discounted

67.395

77.027

- Buyers credit

101.113

76.410

Total

493.295

451.435

 

Banking Relations :

--

 

 

Statutory Auditors :

 

Name :

TD Jain and Dl Sakria

Chartered Accountants

Address :

No. 34, Keshava Nilvas, 3rd Floor, First Main, Gandhinagar, Bangalore-560009, Karnataka, India

Tel. No.:

91-80-22356135/ 22356137

Fax No.:

91-80-22356136

E-Mail :

ostawajaln@gmail.com

 

 

Internal Auditors :

 

Name :

Manjunath S. and Company

Chartered Accountants

Address :

Bangalore, Karnataka, India

 

 

Cost Auditor :

 

Name :

Mr. M.R. Krishnamurthy

Cost Accountant

Address:

Bangalore, Karnataka, India

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Enterprises where principal/ promoter shareholders have control or significant Influence (Significant interest entities) :

Micro Labs Limited

 

 

Related Parties :

·         Desa Marketing International

·         Siroya Developers (Private) Limited

·         Siroya Constructions

·         Siroya Wellness

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2015

 

Authorised Capital : Not Available

 

Issued, Subscribed & Paid-up Capital : Rs. 128.724 Million

 

 

AS ON 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

15000000

Equity Shares

Rs. 10/- each

Rs.150.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

11111388

Equity Shares

Rs. 10/- each

Rs.111.114 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2015

31.03.2014

31.03.2013

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

128.724

111.114

105.736

(b) Reserves & Surplus

407.099

372.018

328.379

(c) Money received against share warrants

20.150

17.364

12.068

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

555.973

500.496

446.183

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

66.443

79.701

16.710

(b) Deferred tax liabilities (Net)

72.858

82.372

82.371

(c) Other long term liabilities

7.459

6.559

18.100

(d) long-term provisions

16.519

10.598

8.350

Total Non-current Liabilities (3)

163.279

179.230

125.531

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

401.379

427.499

443.597

(b) Trade payables

384.865

335.309

320.565

(c) Other current liabilities

117.711

86.593

149.693

(d) Short-term provisions

18.282

18.314

12.807

Total Current Liabilities (4)

922.237

867.715

926.662

 

 

 

 

TOTAL

1641.489

1547.441

1498.376

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

526.729

503.131

467.410

(ii) Intangible Assets

0.000

48.657

50.871

(iii) Capital work-in-progress

0.000

2.459

8.750

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

10.950

0.150

0.150

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

54.041

39.643

38.346

(e) Other Non-current assets

3.295

2.236

2.660

Total Non-Current Assets

595.015

596.276

568.187

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

357.717

317.142

336.870

(c) Trade receivables

449.876

454.882

434.390

(d) Cash and cash equivalents

45.380

30.242

45.335

(e) Short-term loans and advances

191.507

147.619

111.071

(f) Other current assets

1.994

1.280

2.523

Total Current Assets

1046.474

951.165

930.189

 

 

 

 

TOTAL

1641.489

1547.441

1498.376

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2015

31.03.2014

31.03.2013

 

SALES

 

 

 

 

 

Income

1871.300

1788.721

1479.145

 

 

Other Income

11.948

6.463

6.593

 

 

TOTAL                                     (A)

1883.248

1795.184

1485.738

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

961.171

891.184

713.407

 

 

Purchases of Stock-in-Trade

62.289

51.541

44.016

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(31.468)

9.594

24.471

 

 

Employees benefits expense

319.624

281.236

236.493

 

 

Other expenses

384.423

376.398

288.570

 

 

TOTAL                                     (B)

1696.039

1609.953

1306.957

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

187.209

185.231

178.781

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

65.162

71.574

79.768

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

122.047

113.657

99.013

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

70.035

47.397

48.122

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

52.012

66.260

50.891

 

 

 

 

 

Less

TAX                                                                  (H)

11.784

15.537

8.056

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

40.228

50.723

42.835

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

FOB value of exports

NA

1030.466

822.880

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

379.152

301.342

 

 

Capital Goods

 

6.610

3.191

 

TOTAL IMPORTS

NA

385.762

304.533

 

 

 

 

 

 

Earnings Per Share (Rs.)

3.14

4.77

4.05

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2015

31.03.2014

31.03.2013

Current Maturities of Long term borrowings

NA

15.246

73.111

 

 

 

 

Cash generated from/(used in) operations

NA

144.688

176.273

 

 

 

 

Net cash flow from/(used in) operating activities

NA

133.133

161.441

 

 

KEY RATIOS

 

 

PARTICULARS

 

 

31.03.2015

31.03.2014

31.03.2013

Net Profit Margin

(PAT / Sales)

(%)

2.15

2.84

2.90

 

 

 

 

 

Operating Profit Margin

(PBDIT/Sales)

(%)

10.00

10.36

12.09

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

3.19

4.29

3.42

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.09

0.13

0.11

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.84

1.04

1.20

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.13

1.10

1.00

 

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

 

STOCK PRICES

 

Face Value

Rs. 10.00/-

 

 

Market Value

Rs. 81.45/-


 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

105.736

111.114

128.724

Reserves & Surplus

328.379

372.018

407.099

Money received against share warrants

12.068

17.364

20.150

Share Application money pending allotment

0.000

0.000

0.000

Net worth

446.183

500.496

555.973

 

 

 

 

Long-term borrowings

16.710

79.701

66.443

Short term borrowings

443.597

427.499

401.379

Total borrowings

533.418

522.446

467.822

Debt/Equity ratio

1.196

1.044

0.841

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

1479.145

1788.721

1871.300

 

 

20.929

4.617

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

1479.145

1788.721

1871.300

Profit

42.835

50.723

40.228

 

2.90%

2.84%

2.15%

 

 


LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

No

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

Yes

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

 

LITIGATION DETAILS

 

HIGH COURT OF KARNATAKA - PRINCIPAL BENCH AT BANGALORE ITA 238/2013

 

Petitioner/Appnt.

THE COMMISSIONER OF INCOME TAX

Respondent/Defnt. Name

M/S BAL PHARMA LIMITED

Petnr./Appnt. Advocate

K V ARAVIND

Respnt./Defnt Advocate

 

Date Filed

27/05/2013

District

Bangalore City

 

Stage

 

HEARING

Last Posted for

ADMISSION

Last Action Taken

ADMIT/RULE

Last Date of Action

16/07/2013

 

Latest Order:

TO EXAMINE SUBSTANTIAL QUESTIONS OF LAWLIST A/W ITA 239/2013

 

Before Hon'ble Judge/s

D.V.SHYLENDRA KUMAR

B.S.INDRAKALA       

 

 

Lower Court Details [Appeal from below case.]

 

Case No

Court name

Disposal Date

ITA 1263/2011

INCOME TAX APPELLATE TRIBUNAL

04/01/2013

 

Details of the Daily Order

Sl.No.

Honble Judge

Date of Order

1

HONBLE DVSKJ & BSIJ

16/07/2013

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10562042

22/04/2015 *

234,500,000.00

CORPORATION BANK

NO.71/1, BRIGADE PLAZA, SUBEDAR CHATRAM ROAD, BENG
ALURU-560099, KARNATAKA, INDIA

C52692217

2

10416826

18/07/2013 *

60,000,000.00

EXPORT-IMPORT BANK OF INDIA

CENTRE ONE BUILDING, FLOOR 21, WORLD TRADE CENTER
COMPLEX, CUFFE PARADE, MUMBAI-- 400005, MAHARASHTRA, INDIA

B80384944

3

10370582

21/07/2012

6,570,000.00

CANARA BANK

OVERSEAS BRANCH ,M.G. ROAD, BANGALORE- 560001, KARNATAKA, INDIA

B45684024

4

10269289

31/01/2011

30,000,000.00

CANARA BANK

OVERSEAS BRANCH, RAMANASHREE ARCADE, NO.18, M G R
OAD, BANGALORE- 560001, KARNATAKA, INDIA

B07366156

5

10002968

26/03/2010 *

216,500,000.00

EXPORT IMPORT BANK OF INDIA

FLOOR NO.21, CENTRE ONE BUILDING, WORLD TRADE CEN
TRE, CUFFEE PARADE, MUMBAI-400005, MAHARASHTRA,
INDIA

A84530880

6

80022084

22/04/2015 *

580,000,000.00

CANARA BANK (LEADER)

OVERSEAS BRNCH, RAMANASHREE ARCADE, NO.18, M G RO
AD, BENGALURU- 560001, KARNATAKA, INDIA

C52862356

 

* Date of charge modification

 

 

UNSECURED LOANS

 

PARTICULARS

31.03.2014

(Rs. In Million)

31.03.2013

(Rs. In Million)

LONG-TERM BORROWINGS

 

 

Term Loans

 

 

From Banks

 

 

Kotak Mahindra Bank

7.530

1.805

From Financial institutions

0.000

0.000

Tata Capital Limited

0.000

1.857

Magma Fincorp Limited

4.426

3.086

Bajaj Finance Limited

1.949

0.000

 

 

 

SHORT TERM BORROWINGS

 

 

Interest free loan and advances from directors repayable on demand

0.000

2.124

Total

13.905

8.872

 

 

CORPORATE INFORMATION: (AS ON 31.03.2014)

 

Bal Pharma Limited (the company) is a Public Limited Company domiciled in India and incorporated under provisions of the Companies Act, 1956. Its shares are listed on two recognized stock exchanges in India. The company is engaged in the manufacturing and selling of pharmaceutical products. The company caters to both domestic and international markets.

 

 

FIXED ASSETS:

 

Tangible Assets

 

·         Buildings

·         Plant and Machinery

·         Furniture and Fixtures

·         Vehicles

·         Office Equipment

·         Utilities

·         Leasehold LAND

·         Freehold Land

 

Intangible assets

 

·         Software

·         R and D Expenses

·         Market Development Expenditure

 

 

 

 


 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs. 64.83

UK Pound

1

  Rs. 101.00

Euro

1

Rs. 71.82

 

 

INFORMATION DETAILS

 

Information Gathered by :

PRI

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

IND

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

50

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.